(+)-pilocarpine increases expression ISO RGD:1563119 6480464 Pilocarpine results in increased expression of MEF2C mRNA CTD PMID:18949272 (S)-nicotine affects expression ISO RGD:1563119 6480464 Nicotine affects the expression of MEF2C mRNA CTD PMID:20426880 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of MEF2C mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:1563119 6480464 1-Naphthylisothiocyanate results in decreased expression of MEF2C mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1349172 6480464 Estradiol results in increased expression of MEF2C mRNA CTD PMID:23094148 17beta-estradiol decreases expression ISO RGD:1563119 6480464 Estradiol results in decreased expression of MEF2C mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO RGD:1349172 6480464 IGF1R mutant form inhibits the reaction [Estradiol results in increased expression of MEF2C mRNA] CTD PMID:23094148 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1349172 6480464 Dihydrotestosterone results in increased expression of MEF2C mRNA CTD PMID:18007998 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1563119 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1349172 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MEF2C mRNA CTD PMID:24058054 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1563119 6480464 Tetrachlorodibenzodioxin affects the expression of MEF2C mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1563119 6480464 Tetrachlorodibenzodioxin results in decreased expression of MEF2C mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MEF2C mRNA CTD PMID:19465110 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1563119 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol decreases expression EXP 6480464 n-butoxyethanol results in decreased expression of MEF2C mRNA CTD PMID:19812364 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of MEF2C mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MEF2C mRNA CTD PMID:19285098 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MEF2C mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of MEF2C mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MEF2C mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of MEF2C exon CTD PMID:33297965 5-aza-2'-deoxycytidine increases expression ISO RGD:1349172 6480464 Decitabine results in increased expression of MEF2C mRNA CTD PMID:19151715 acadesine decreases expression ISO RGD:1349172 6480464 acadesine results in decreased expression of MEF2C mRNA CTD PMID:15864539 acrylamide decreases expression ISO RGD:1349172 6480464 Acrylamide results in decreased expression of MEF2C mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MEF2C mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1349172 6480464 Aflatoxin B1 results in decreased methylation of MEF2C gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1349172 6480464 Aflatoxin B1 results in decreased expression of MEF2C mRNA CTD PMID:22100608 Aflatoxin B2 alpha decreases methylation ISO RGD:1349172 6480464 aflatoxin B2 results in decreased methylation of MEF2C intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1349172 6480464 Tretinoin results in increased expression of MEF2C mRNA CTD PMID:21934132 , PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:1349172 6480464 Tretinoin results in decreased expression of MEF2C mRNA CTD PMID:23724009 amiodarone increases expression ISO RGD:1349172 6480464 Amiodarone results in increased expression of MEF2C mRNA CTD PMID:19774075 amphetamine decreases expression ISO RGD:1563119 6480464 Amphetamine results in decreased expression of MEF2C mRNA CTD PMID:30779732 amphotericin B decreases expression ISO RGD:1349172 6480464 Amphotericin B analog results in decreased expression of MEF2C mRNA CTD PMID:28534445 aristolochic acid A increases expression ISO RGD:1349172 6480464 aristolochic acid I results in increased expression of MEF2C mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:1349172 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of MEF2C mRNA CTD PMID:16934159 arsane affects expression ISO RGD:1349172 6480464 Arsenic affects the expression of MEF2C mRNA CTD PMID:18414638 arsane affects methylation ISO RGD:1349172 6480464 Arsenic affects the methylation of MEF2C gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:1349172 6480464 Arsenic affects the expression of MEF2C mRNA CTD PMID:18414638 arsenic atom affects methylation ISO RGD:1349172 6480464 Arsenic affects the methylation of MEF2C gene CTD PMID:25304211 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of MEF2C mRNA CTD PMID:33053406 benzo[a]pyrene decreases expression ISO RGD:1349172 6480464 Benzo(a)pyrene results in decreased expression of MEF2C mRNA CTD PMID:20064835 benzo[a]pyrene decreases methylation ISO RGD:1349172 6480464 Benzo(a)pyrene results in decreased methylation of MEF2C 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1349172 6480464 Benzo(a)pyrene affects the methylation of MEF2C 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of MEF2C mRNA CTD PMID:21569818 , PMID:22228805 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of MEF2C mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of MEF2C mRNA, Diethylhexyl Phthalate results in decreased expression of MEF2C protein CTD PMID:29377175 bisphenol A increases expression ISO RGD:1349172 6480464 bisphenol A results in increased expression of MEF2C mRNA CTD PMID:18007998 , PMID:31830493 bisphenol A affects expression ISO RGD:1563119 6480464 bisphenol A affects the expression of MEF2C mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MEF2C mRNA CTD PMID:30951980 , PMID:35479511 bisphenol A multiple interactions ISO RGD:1349172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MEF2C mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:1563119 6480464 bisphenol A results in increased expression of MEF2C mRNA CTD PMID:25181051 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of MEF2C mRNA CTD PMID:30951980 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of MEF2C mRNA CTD PMID:29038090 caffeine multiple interactions ISO RGD:1563119 6480464 Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2C mRNA], Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2C protein] CTD PMID:25093688 caffeine increases expression ISO RGD:1563119 6480464 Caffeine results in increased expression of MEF2C mRNA, Caffeine results in increased expression of MEF2C protein CTD PMID:25093688 cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of MEF2C mRNA CTD PMID:21542829 CGP 52608 multiple interactions ISO RGD:1349172 6480464 CGP 52608 promotes the reaction [RORA protein binds to MEF2C gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of MEF2C mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of MEF2C mRNA CTD PMID:20350560 chrysene increases expression EXP 6480464 chrysene results in increased expression of MEF2C mRNA CTD PMID:26377693 crocidolite asbestos decreases expression EXP 6480464 Asbestos, Crocidolite results in decreased expression of MEF2C mRNA CTD PMID:29279043 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of MEF2C mRNA CTD PMID:27237783 cyclosporin A increases expression ISO RGD:1349172 6480464 Cyclosporine results in increased expression of MEF2C mRNA CTD PMID:20106945 dantrolene multiple interactions ISO RGD:1563119 6480464 Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2C mRNA], Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2C protein] CTD PMID:25093688 dexamethasone multiple interactions ISO RGD:1349172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MEF2C mRNA CTD PMID:28628672 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MEF2C mRNA CTD PMID:17361019 , PMID:21266533 dimethyl sulfoxide increases expression ISO RGD:1349172 6480464 Dimethyl Sulfoxide results in increased expression of MEF2C mRNA CTD PMID:22105179 dimethyl sulfoxide decreases expression ISO RGD:1349172 6480464 Dimethyl Sulfoxide results in decreased expression of MEF2C mRNA CTD PMID:22105179 dimethylarsinic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA CTD PMID:34876320 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEF2C mRNA CTD PMID:30529165 diquat decreases expression EXP 6480464 Diquat results in decreased expression of MEF2C mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1563119 6480464 EP300 inhibits the reaction [Doxorubicin results in decreased expression of MEF2C mRNA] CTD PMID:11073966 doxorubicin decreases expression ISO RGD:1349172 6480464 Doxorubicin results in decreased expression of MEF2C mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:1563119 6480464 Doxorubicin results in decreased expression of MEF2C mRNA CTD PMID:11073966 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of MEF2C mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1349172 6480464 Ethyl Methanesulfonate results in decreased expression of MEF2C mRNA CTD PMID:23649840 fenvalerate decreases expression ISO RGD:1563119 6480464 fenvalerate results in decreased expression of MEF2C mRNA CTD PMID:30307764 ferric oxide decreases expression EXP 6480464 ferric oxide analog results in decreased expression of MEF2C mRNA CTD PMID:25086211 formaldehyde decreases expression ISO RGD:1349172 6480464 Formaldehyde results in decreased expression of MEF2C mRNA CTD PMID:23649840 fructose increases expression ISO RGD:1563119 6480464 Fructose results in increased expression of MEF2C mRNA CTD PMID:36049592 gentamycin increases expression ISO RGD:1563119 6480464 Gentamicins results in increased expression of MEF2C mRNA CTD PMID:33387578 Goe 6976 multiple interactions EXP 6480464 Go 6976 inhibits the reaction [Phenylephrine results in increased activity of MEF2C protein] CTD PMID:19124542 hydrogen cyanide decreases expression EXP 6480464 Hydrogen Cyanide results in decreased expression of MEF2C mRNA CTD PMID:33914522 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of MEF2C mRNA CTD PMID:23562911 hydrogen peroxide multiple interactions ISO RGD:1349172 6480464 [SNCA gene mutant form results in increased susceptibility to Hydrogen Peroxide] which results in increased metabolism of MEF2C protein CTD PMID:24290359 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of MEF2C mRNA CTD PMID:23562911 icariin increases expression EXP 6480464 icariin results in increased expression of MEF2C mRNA CTD PMID:18423597 icariin affects localization EXP 6480464 icariin affects the localization of MEF2C protein CTD PMID:18423597 icariin multiple interactions EXP 6480464 SB 203580 inhibits the reaction [icariin affects the localization of MEF2C protein] more ... CTD PMID:18423597 indometacin multiple interactions ISO RGD:1349172 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MEF2C mRNA CTD PMID:28628672 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of MEF2C mRNA CTD PMID:20003209 isoprenaline increases expression ISO RGD:1563119 6480464 Isoproterenol results in increased expression of MEF2C mRNA CTD PMID:30303030 isotretinoin increases expression ISO RGD:1349172 6480464 Isotretinoin results in increased expression of MEF2C mRNA CTD PMID:20436886 isoxazoles increases expression ISO RGD:1349172 6480464 Isoxazoles results in increased expression of MEF2C mRNA CTD PMID:24290359 lead(0) affects expression ISO RGD:1349172 6480464 Lead affects the expression of MEF2C mRNA CTD PMID:28903495 maneb multiple interactions ISO RGD:1349172 6480464 [Maneb promotes the reaction [SNCA gene mutant form results in increased susceptibility to Paraquat]] which results in increased metabolism of MEF2C protein, [Paraquat promotes the reaction [SNCA gene mutant form results in increased susceptibility to Maneb]] which results in increased metabolism of MEF2C protein CTD PMID:24290359 manganese(II) chloride decreases expression ISO RGD:1563119 6480464 manganese chloride results in decreased expression of MEF2C mRNA CTD PMID:28801915 manganese(II) chloride increases methylation ISO RGD:1563119 6480464 manganese chloride results in increased methylation of MEF2C gene CTD PMID:28801915 metformin increases expression ISO RGD:1349172 6480464 Metformin results in increased expression of MEF2C mRNA CTD PMID:15864539 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of MEF2C mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:1349172 6480464 Methyl Methanesulfonate results in decreased expression of MEF2C mRNA CTD PMID:23649840 methylarsonic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA CTD PMID:34876320 methylmercury chloride decreases expression ISO RGD:1349172 6480464 methylmercuric chloride results in decreased expression of MEF2C mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO RGD:1349172 6480464 methylselenic acid results in increased expression of MEF2C mRNA CTD PMID:18548127 mifepristone decreases expression ISO RGD:1563119 6480464 Mifepristone results in decreased expression of MEF2C mRNA CTD PMID:25972201 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1563119 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MEF2C mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases methylation ISO RGD:1563119 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of MEF2C gene CTD PMID:28801915 nickel atom increases expression EXP 6480464 Nickel results in increased expression of MEF2C mRNA CTD PMID:18922574 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of MEF2C mRNA CTD PMID:16166746 nicotine affects expression ISO RGD:1563119 6480464 Nicotine affects the expression of MEF2C mRNA CTD PMID:20426880 nitrofen decreases expression ISO RGD:1563119 6480464 nitrofen results in decreased expression of MEF2C mRNA CTD PMID:18280291 oxaliplatin multiple interactions ISO RGD:1563119 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MEF2C mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1349172 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MEF2C mRNA CTD PMID:26035830 panobinostat increases expression ISO RGD:1349172 6480464 panobinostat results in increased expression of MEF2C mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEF2C mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1349172 6480464 Acetaminophen results in increased expression of MEF2C mRNA CTD PMID:29067470 paraquat multiple interactions ISO RGD:1349172 6480464 [Maneb promotes the reaction [SNCA gene mutant form results in increased susceptibility to Paraquat]] which results in increased metabolism of MEF2C protein, [Paraquat promotes the reaction [SNCA gene mutant form results in increased susceptibility to Maneb]] which results in increased metabolism of MEF2C protein CTD PMID:24290359 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of MEF2C mRNA, perfluorooctane sulfonic acid results in decreased expression of MEF2C protein CTD PMID:23562911 , PMID:26178269 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of MEF2C mRNA CTD PMID:23562911 phenylephrine multiple interactions EXP 6480464 Go 6976 inhibits the reaction [Phenylephrine results in increased activity of MEF2C protein] CTD PMID:19124542 phenylephrine increases expression ISO RGD:1563119 6480464 Phenylephrine results in increased expression of MEF2C mRNA CTD PMID:10737771 phenylephrine multiple interactions ISO RGD:1563119 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA], KN 62 inhibits the reaction [Phenylephrine results in increased expression of MEF2C mRNA] CTD PMID:10737771 phenylephrine increases activity EXP 6480464 Phenylephrine results in increased activity of MEF2C protein CTD PMID:19124542 phenylmercury acetate increases expression ISO RGD:1349172 6480464 Phenylmercuric Acetate results in increased expression of MEF2C mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEF2C mRNA CTD PMID:27188386 phosgene affects expression EXP 6480464 Phosgene affects the expression of MEF2C mRNA CTD PMID:16300373 pioglitazone multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MEF2C mRNA CTD PMID:27935865 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of MEF2C mRNA CTD PMID:18445702 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of MEF2C mRNA CTD PMID:17951219 poly(I:C) multiple interactions ISO RGD:1563119 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of MEF2C mRNA CTD PMID:26923065 resveratrol increases expression ISO RGD:1349172 6480464 resveratrol results in increased expression of MEF2C mRNA CTD PMID:12002526 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of MEF2C mRNA CTD PMID:22610192 rimonabant multiple interactions EXP 6480464 Rimonabant inhibits the reaction [Dronabinol results in increased expression of MEF2C mRNA] CTD PMID:36529297 rofecoxib affects expression ISO RGD:1349172 6480464 rofecoxib affects the expression of MEF2C mRNA CTD PMID:17070997 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [icariin affects the localization of MEF2C protein], SB 203580 inhibits the reaction [icariin results in increased expression of MEF2C mRNA] CTD PMID:18423597 SB 431542 multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of MEF2C mRNA CTD PMID:19073995 silver atom decreases expression EXP 6480464 Silver results in decreased expression of MEF2C mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of MEF2C mRNA CTD PMID:27131904 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of MEF2C mRNA CTD PMID:21795629 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA CTD PMID:34876320 sodium arsenite affects localization EXP 6480464 sodium arsenite affects the localization of MEF2C protein CTD PMID:20965206 sodium arsenite multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA CTD PMID:34876320 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MEF2C mRNA, sodium arsenite results in decreased expression of MEF2C protein CTD PMID:20965206 spermine increases expression EXP 6480464 Spermine results in increased expression of MEF2C mRNA CTD PMID:18673383 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of MEF2C mRNA CTD PMID:27629361 streptozocin multiple interactions ISO RGD:1349172 6480464 SOD1 protein inhibits the reaction [Streptozocin results in decreased expression of MEF2C mRNA] CTD PMID:27629361 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2C mRNA CTD PMID:21641980 temozolomide increases expression ISO RGD:1349172 6480464 Temozolomide results in increased expression of MEF2C mRNA CTD PMID:31758290 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of MEF2C mRNA CTD PMID:17484886 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of MEF2C mRNA CTD PMID:23557971 topotecan multiple interactions ISO RGD:1563119 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MEF2C mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1563119 6480464 Trichloroethylene results in increased expression of MEF2C mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1349172 6480464 trichostatin A results in increased expression of MEF2C mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEF2C mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1349172 6480464 Triclosan results in decreased expression of MEF2C mRNA CTD PMID:30510588 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of MEF2C mRNA CTD PMID:19042947 valproic acid increases expression ISO RGD:1349172 6480464 Valproic Acid results in increased expression of MEF2C mRNA CTD PMID:19101580 more ... valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MEF2C mRNA CTD PMID:27237783 valproic acid multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEF2C mRNA CTD PMID:27188386 vinclozolin affects expression ISO RGD:1563119 6480464 vinclozolin affects the expression of MEF2C mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:1349172 6480464 vorinostat results in increased expression of MEF2C mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1349172 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEF2C mRNA CTD PMID:27188386